Literature DB >> 6950180

Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.

A Neri, D Welch, T Kawaguchi, G L Nicolson.   

Abstract

With the use of the rat 13762 mammary adenocarcinoma tumor, an animal model for spontaneous mammary tumor metastasis was developed. The parental tumor implanted sc into the mammary fat pads of female Fischer 344 rats metastasized at low frequency to lymph nodes and lung and did not metastasize to other organs. Oophorectomy did not modify the metastatic properties of the parental 13762 tumor. Cell lines were adapted to tissue culture from lymph node or lung metastases, and these were compared to parental tumor transplants in spontaneous metastasis assays. Only the cell lines established from metastases were spontaneously metastatic within 23 days after sc implantation, indicating that tumor cell populations from metastases are more metastatic than are cells from the parental tumor. Several individual parental tumor-derived and lung metastasis-derived clones were compared for spontaneous metastatic potentials, cell culture morphologies, histologic structures at primary implant and secondary metastatic sites, and growth characteristics in vivo and in vitro. There was no correlation between any of these tumor and cellular properties and metastatic potential. The parental mammary tumor-derived, lymph node metastasis-derived, and lung metastasis-derived cell lines and clones with differing spontaneous metastatic properties should prove useful in studies on the roles of tumor cell and host properties in lymphatic and blood-borne metastasis.

Entities:  

Mesh:

Year:  1982        PMID: 6950180

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  97 in total

1.  Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines.

Authors:  S J Hall; T C Thompson
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  Effects of gamma irradiation on cultured rat and mouse microvessel endothelial cells: metastatic tumor cell adhesion, subendothelial matrix degradation, and secretion of tumor cell growth factors.

Authors:  G L Nicolson; S E Custead; K M Dulski; L Milas
Journal:  Clin Exp Metastasis       Date:  1991 Sep-Oct       Impact factor: 5.150

Review 3.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 4.  Quantitative genetic analysis of tumor progression.

Authors:  V Ling; A F Chambers; J F Harris; R P Hill
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

5.  Characterization of brain and bone-metastasizing clones selected from an ethylnitrosourea-induced rat mammary carcinoma.

Authors:  D G Hall; G Stoica
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

6.  Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases.

Authors:  J P Volpe; L Milas
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

7.  Imaging tumor cell movement in vivo.

Authors:  David Entenberg; Dmitriy Kedrin; Jeffrey Wyckoff; Erik Sahai; John Condeelis; Jeffrey E Segall
Journal:  Curr Protoc Cell Biol       Date:  2013-03

Review 8.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Survival of rat mammary tumor cell clones and DNA strand damage following adriamycin treatment.

Authors:  D P Evans; R E Meyn; S P Tomasovic
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Different biological behavior of AKR lymphoma cells from primary and metastatic tumors.

Authors:  J Leibovici; Y Stark; S Kopel
Journal:  Experientia       Date:  1985-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.